Loading clinical trials...

A Phase 2b Study of Icosabutate in Fatty Liver Disease | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT04052516

A Phase 2b Study of Icosabutate in Fatty Liver Disease

A Phase 2b study to evaluate the efficacy of different doses of NST-4016 on the resolution of NASH without worsening of fibrosis

Lead sponsor: NorthSea Therapeutics B.V.•38 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

TERMINATEDPhase 2

Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis.

NCT04065841 · Non Alcoholic Steatohepatitis (NASH)

TERMINATEDPhase 3

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment

NCT02548351 · Non Alcoholic Steatohepatitis (NASH)

UNKNOWNPhase 2

Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis

NCT04880187 · Non Alcoholic Steatohepatitis (NASH)

COMPLETEDPhase 3

DHA and Vitamin D in Children With Biopsy-proven NAFLD

NCT02098317 · NAFLD, Non Alcoholic Steatohepatitis (NASH)

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 28, 2025Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment280

Start dateJul 2019

Last updatedFeb 28, 2025

Condition

Non Alcoholic Steatohepatitis (NASH)

Locations shown

Central ResearchAssociates Inc.

Birmingham, Alabama

Arizona Liver Health

Chandler, Arizona

Arizona Liver Health - Glendale

Glendale, Arizona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 28, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions